|
1
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu X, Zhong J, Zhou X, Wei Z, Xia Q, Huang
P, Shi C, Da J, Tang C, Cheng W and Ge J: Mucinous tubular and
spindle cell carcinoma of the kidney: A study of clinical, imaging
features and treatment outcomes. Front Oncol. 12:8652632022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li XS, Yao L, Gong K, Yu W, He Q, Zhou LQ
and He ZS: Growth pattern of renal cell carcinoma (RCC) in patients
with delayed surgical intervention. J Cancer Res Clin Oncol.
138:269–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cornelis F, Ambrosetti D, Rocher L, Derchi
LE, Renard B, Puech P, Claudon M, Rouvière O, Ferlicot S, Roy C, et
al: CT and MR imaging features of mucinous tubular and spindle cell
carcinoma of the kidneys. A multi-institutional review. Eur Radiol.
27:1087–1095. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu J, Zhu Q, Zhu W, Chen W and Wang S:
Comparative study of CT appearances in mucinous tubular and spindle
cell carcinoma and collecting duct carcinoma of the kidney. Br J
Radiol. 88:201404342015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nathany S and Monappa V: Mucinous tubular
and spindle cell carcinoma: A review of histopathology and clinical
and prognostic implications. Arch Pathol Lab Med. 144:115–118.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ivey JA III, Cortese C, Baird BA, Thiel DD
and Lyon TD: Mucinous tubular and spindle cell carcinoma of the
kidney with nodal metastasis managed with surgical resection. Eur
Urol Open Sci. 29:10–14. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fine SW, Argani P, DeMarzo AM, Delahunt B,
Sebo TJ, Reuter VE and Epstein JI: Expanding the histologic
spectrum of mucinous tubular and spindle cell carcinoma of the
kidney. Am J Surg Pathol. 30:1554–1560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ged Y, Chen YB, Knezevic A, Donoghue MTA,
Carlo MI, Lee CH, Feldman DR, Patil S, Hakimi AA, Russo P, et al:
Mucinous tubular and spindle-cell carcinoma of the kidney: Clinical
features, genomic profiles, and treatment outcomes. Clin Genitourin
Cancer. 17:268–274.e1. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trpkov K, Hes O, Williamson SR, Adeniran
AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L,
et al: New developments in existing WHO entities and evolving
molecular concepts: The genitourinary pathology society (GUPS)
update on renal neoplasia. Mod Pathol. 34:1392–1424. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Farghaly H: Mucin poor mucinous tubular
and spindle cell carcinoma of the kidney, with nonclassic
morphologic variant of spindle cell predominance and psammomatous
calcification. Ann Diagn Pathol. 16:59–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thway K, du Parcq J, Larkin JMG, Fisher C
and Livni N: Metastatic renal mucinous tubular and spindle cell
carcinoma. Atypical behavior of a rare, morphologically bland
tumor. Ann Diagn Pathol. 16:407–410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang C, Cimera RS, Aryeequaye R,
Jayakumaran G, Sarungbam J, Al-Ahmadie HA, Gopalan A, Sirintrapun
SJ, Fine SW, Tickoo SK, et al: Adverse histology, homozygous loss
of CDKN2A/B, and complex genomic alterations in locally
advanced/metastatic renal mucinous tubular and spindle cell
carcinoma. Mod Pathol. 34:445–456. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brandal P, Lie AK, Bassarova A, Svindland
A, Risberg B, Danielsen H and Heim S: Genomic aberrations in
mucinous tubular and spindle cell renal cell carcinomas. Mod
Pathol. 19:186–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cossu-Rocca P, Eble JN, Delahunt B, Zhang
S, Martignoni G, Brunelli M and Cheng L: Renal mucinous tubular and
spindle carcinoma lacks the gains of chromosomes 7 and 17 and
losses of chromosome Y that are prevalent in papillary renal cell
carcinoma. Mod Pathol. 19:488–493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Zhang Y, Chen YB, Skala SL,
Al-Ahmadie HA, Wang X, Cao X, Veeneman BA, Chen J, Cieślik M, et
al: VSTM2A overexpression is a sensitive and specific biomarker for
mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney.
Am J Surg Pathol. 42:1571–1584. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao M, He XL and Teng XD: Mucinous
tubular and spindle cell renal cell carcinoma: A review of
clinicopathologic aspects. Diagn Pathol. 10:1682015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Truong LD and Shen SS: Immunohistochemical
diagnosis of renal neoplasms. Arch Pathol Lab Med. 135:92–109.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paner GP, Srigley JR, Radhakrishnan A,
Cohen C, Skinnider BF, Tickoo SK, Young AN and Amin MB:
Immunohistochemical analysis of mucinous tubular and spindle cell
carcinoma and papillary renal cell carcinoma of the kidney:
Significant immunophenotypic overlap warrants diagnostic caution.
Am J Surg Pathol. 30:13–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moll R, Divo M and Langbein L: The human
keratins: Biology and pathology. Histochem Cell Biol. 129:705–733.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferlicot S, Allory Y, Compérat E,
Mege-Lechevalier F, Dimet S, Sibony M, Couturier J and Vieillefond
A: Mucinous tubular and spindle cell carcinoma: A report of 15
cases and a review of the literature. Virchows Arch. 447:978–983.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szlasa W, Wilk K, Knecht-Gurwin K, Gurwin
A, Froń A, Sauer N, Krajewski W, Saczko J, Szydełko T, Kulbacka J
and Małkiewicz B: Prognostic and therapeutic role of CD15 and CD15s
in cancer. Cancers (Basel). 14:22032022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kenney PA, Vikram R, Prasad SR, Tamboli P,
Matin SF, Wood CG and Karam JA: Mucinous tubular and spindle cell
carcinoma (MTSCC) of the kidney: A detailed study of radiological,
pathological and clinical outcomes. BJU Int. 116:85–92. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu D, Yuan W, Zhu Q, Ye J, Zhu W and Chen
W: Comparative study of CT and MRI appearances in mucinous tubular
and spindle cell carcinoma and papillary renal cell carcinoma. Br J
Radiol. 94:202105482021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adamane SA, Menon S, Prakash G, Bakshi G,
Joshi A, Popat P and Desai SB: Mucinous tubular and spindle cell
carcinoma of the kidney: A case series with a brief review of the
literature. Indian J Cancer. 57:267–281. 2020.PubMed/NCBI
|
|
26
|
Zhu Q, Zhu W, Wang Z and Wu J: Clinical
and CT imaging features of mucinous tubular and spindle cell
carcinoma. Chin Med J (Engl). 127:1278–1283. 2014.PubMed/NCBI
|
|
27
|
Israel GM and Bosniak MA: How i do it:
Evaluating renal masses. Radiology. 236:441–450. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oliva MR, Glickman JN, Zou KH, Teo SY,
Mortelé KJ, Rocha MS and Silverman SG: Renal cell carcinoma: t1 and
t2 signal intensity characteristics of papillary and clear cell
types correlated with pathology. AJR Am J Roentgenol.
192:1524–1530. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Furubayashi N, Taguchi K, Negishi T, Miura
A, Sato Y, Miyoshi M and Nakamura M: Cytoreductive nephrectomy
after combination of nivolumab plus ipilimumab for mucinous tubular
and spindle cell carcinoma of the kidney with bone metastases: A
case report. In Vivo. 36:510–521. 2022. View Article : Google Scholar : PubMed/NCBI
|
